Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid

被引:59
|
作者
Ruedrich, Urda [1 ]
Gehring, Manuela [1 ]
Papakonstantinou, Eleni [1 ]
Illerhaus, Anja [2 ]
Engmann, Judith [1 ]
Kapp, Alexander [1 ]
Hartmann, Karin [3 ]
Meyer, N. Helge [4 ]
Gibbs, Bernhard F. [4 ]
Raap, Ulrike [1 ,4 ]
机构
[1] Hannover Med Sch, Dept Dermatol & Allergol, Hannover, Germany
[2] Univ Cologne, Dept Dermatol, Cologne, Germany
[3] Med Univ Lubeck, Dept Dermatol & Allergol, Lubeck, Germany
[4] Carl von Ossietzky Univ Oldenburg, Dept Human Med, Dermatol & Allergol, Oldenburg, Germany
关键词
bullous pemphigoid; IL-31; itch; pruritus; eosinophils; IL-31; SERUM-LEVELS; T-CELLS; ATOPIC-DERMATITIS; DISEASE-ACTIVITY; CORRELATE; RECEPTOR; EXPRESSION; PRURITUS; SKIN; SEVERITY;
D O I
10.2340/00015555-2951
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Bullous pemphigoid (BP) is characterized by substantial skin and blood eosinophilia as well as intensive pruritus. Since the pruritogenic cytokine interleukin (IL)-31 is increased in inflammatory skin diseases the aim of this study was to determine whether IL-31 plays a role in BP. Using immunofluorescence, IL-31 expression was analysed in eosinophils derived from blister fluids and skin from patients with BP and IL-31 levels in blister fluids, serum and culture supernatants were determined by enzyme-linked immunoassay (ELISA). High levels of IL-31 expression were observed in BP blister fluids, but they were only marginally elevated in BP serum compared with healthy controls. Eosinophils from either BP blister fluids or skin biopsies showed strong expression of IL-31. Furthermore, peripheral blood eosinophils from patients with BP, but not healthy controls, released high levels of IL-31, reflecting those in blister fluids. In conclusion, eosinophils are a major source of IL-31 in BP and this cytokine may contribute to itch in patients with BP.
引用
收藏
页码:766 / 771
页数:6
相关论文
共 50 条
  • [21] Interleukin-31 as early Success Marker of Immunotherapy?
    Bauer-Delto, Angelika
    ALLERGO JOURNAL, 2013, 22 (03) : 209 - 209
  • [23] Interleukin-31 and Chronic Pruritus of Unknown Origin
    Salao, Kanin
    Sawanyawisuth, Kittisak
    Winaikosol, Kengkart
    Choonhakarn, Charoen
    Chaowattanapanit, Suteeraporn
    BIOMARKER INSIGHTS, 2020, 15
  • [24] Activation of FcεRI-positive eosinophils in bullous pemphigoid
    Kasahara-Imamura, M
    Hosokawa, H
    Maekawa, N
    Horio, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (03) : 249 - 253
  • [25] BULLOUS PEMPHIGOID BLISTER FLUIDS INFLUENCE THE DENSITY DISTRIBUTION OF EOSINOPHILS
    IRYO, K
    MIYASATO, M
    KIYONAGA, H
    TANAKA, K
    TSUDA, S
    SASAI, Y
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1987, 279 (08) : 558 - 560
  • [26] INTERLEUKIN-2 PRODUCTION IN BULLOUS PEMPHIGOID
    AHMED, AR
    HIJRI, K
    ARABKERMANI, V
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1984, 276 (05) : 330 - 332
  • [27] Itch, Eosinophils, and Autoimmunity: A Novel Murine Model of Bullous Pemphigoid
    Yancey, Kim B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (05) : 1213 - 1215
  • [28] PEMPHIGOID VEGETANS REPRESENTS A BULLOUS PEMPHIGOID VARIANT - PATIENTS IGG AUTOANTIBODIES IDENTIFY THE MAJOR BULLOUS PEMPHIGOID ANTIGEN
    CHAN, LS
    DORMAN, MA
    AGHA, A
    SUZUKI, T
    COOPER, KD
    HASHIMOTO, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (02) : 331 - 335
  • [29] Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis
    Nakahara T.
    Furue M.
    Current Treatment Options in Allergy, 2018, 5 (4) : 405 - 414
  • [30] Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer
    Akhtar, Sabah
    Ahmad, Fareed
    Alam, Majid
    Ansari, Abdul Wahid
    Uddin, Shahab
    Steinhoff, Martin
    Buddenkotte, Joerg
    Ahmad, Aamir
    Datsi, Angeliki
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (09):